UBS Group’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.15K | Sell |
|
|||||
|
2025
Q1 | $8.41K | Sell |
|
|||||
|
2024
Q4 | $56.8K | Buy |
|
|||||
|
2024
Q3 | $36.1K | Buy |
|
|||||
|
2024
Q2 | $16.3K | Sell |
|
|||||
|
2024
Q1 | $224K | Buy |
|
|||||
|
2023
Q4 | $232K | Buy |
|
|||||
|
2023
Q3 | $185K | Sell |
|
|||||
|
2023
Q2 | $163K | Buy |
|
|||||
|
2023
Q1 | $46.6K | Buy |
|
|||||
|
2022
Q4 | $31.2K | Sell |
|
|||||
|
2022
Q3 | $36K | Buy |
|
|||||
|
2022
Q2 | $34K | Buy |
|
|||||
|
2022
Q1 | $47K | Sell |
|
|||||
|
2021
Q4 | $62K | Buy |
|
|||||
|
2021
Q3 | $50K | Hold |
|
|||||
|
2021
Q2 | $59K | Sell |
|
|||||
|
2021
Q1 | $81K | Sell |
|
|||||
|
2020
Q4 | $2.38M | Buy |
|
|||||
|
2020
Q3 | $2.58M | Buy |
|
|||||
|
2020
Q2 | $980K | Sell |
|
|||||
|
2020
Q1 | $620K | Buy |
|
|||||
|
2019
Q4 | $17K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $13K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $24K | Buy |
|
|||||
|
2018
Q3 | $19K | Buy |
|
|||||
|
2018
Q2 | $23K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $2K | Sell |
|
|||||
|
2017
Q3 | $15K | Buy |
|